1-5 of 5
Sangeetha Venugopal
Close
Sort by
Journal Articles

Olutasidenib: from bench to bedside

Clinical Trials & Observations
Sangeetha Venugopal, Justin Watts
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4358–4365.
https://doi.org/10.1182/bloodadvances.2023009854
Published: 2023
Journal Articles

Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2 -mutant myelodysplastic syndrome

Clinical Trials & Observations
Courtney D. DiNardo, Sangeetha Venugopal, Curtis Lachowiez, Koichi Takahashi, Sanam Loghavi, Guillermo Montalban-Bravo, Xuemei Wang, Hetty Carraway, Mikkael Sekeres, Ameenah Sukkur, Danielle Hammond, Kelly Chien, Abhishek Maiti, Lucia Masarova, Koji Sasaki, Yesid Alvarado, Tapan Kadia, Nicholas J. Short, Naval Daver, Gautam Borthakur, Farhad Ravandi, Hagop M. Kantarjian, Bhumika Patel, Amy Dezern, Gail Roboz, Guillermo Garcia-Manero
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2378–2387.
https://doi.org/10.1182/bloodadvances.2022008378
Published: 2023
Includes: Supplemental data
Journal Articles

Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML

Ghayas C. Issa, Aram Bidikian, Sangeetha Venugopal, Marina Konopleva, Courtney D. DiNardo, Tapan M. Kadia, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Musa Yilmaz, Nicholas J. Short, Abhishek Maiti, Koji Sasaki, Lucia Masarova, Sherry Pierce, Koichi Takahashi, Guilin Tang, Sanam Loghavi, Keyur Patel, Michael Andreeff, Kapil Bhalla, Guillermo Garcia-Manero, Farhad Ravandi, Hagop Kantarjian, Naval Daver
Journal: Blood Advances
Blood Adv (2023) 7 (6): 933–942.
https://doi.org/10.1182/bloodadvances.2022008316
Published: 2023
Includes: Supplemental data
Journal Articles

Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside–based low-intensity therapy

Sangeetha Venugopal, Gautam Borthakur, Naval Daver, Courtney D. DiNardo, Naveen Pemmaraju, Nicholas J. Short, Hussein A. Abbas, Guillermo Garcia-Manero, Marina Konopleva, Farhad Ravandi, Tapan M. Kadia
Journal: Blood Advances
Blood Adv (2022) 6 (19): 5546–5549.
https://doi.org/10.1182/bloodadvances.2021006689
Published: 2022
Journal Articles

The odyssey of pacritinib in myelofibrosis

Sangeetha Venugopal, John Mascarenhas
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4905–4913.
https://doi.org/10.1182/bloodadvances.2022007524
Published: 2022